We are live on
!
Find out more
O
OppenheimerFunds Portfolio holdings
AUM
$80.4B
1-Year Est. Return
15.1%
This Fund
S&P 500
This Quarter
Est. Return
+7.22%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$79.7B
AUM Growth
+$3.42B
(+4.5%)
Cap. Flow
-$854M
Cap. Flow
% of AUM
-1.07%
Top 10 Holdings %
Top 10 Hldgs %
14.29%
Holding
1,817
New
122
Increased
851
Reduced
711
Closed
96
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson Controls International
JCI
|
+$281M |
| 2 |
Comcast
CMCSA
|
+$235M |
| 3 |
Apple
AAPL
|
+$172M |
| 4 |
MetLife
MET
|
+$151M |
| 5 |
Mid-America Apartment Communities
MAA
|
+$148M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$399M |
| 2 |
UBS Group
UBS
|
+$393M |
| 3 |
Televisa
TV
|
+$305M |
| 4 |
TYC
TYCO INTL PLC COM SHS (IRL)
TYC
|
+$278M |
| 5 |
New Oriental
EDU
|
+$169M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 15.42% |
| 2 | Financials | 13.04% |
| 3 | Healthcare | 11.98% |
| 4 | Consumer Discretionary | 11.9% |
| 5 | Technology | 10.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BLUE
301
DELISTED
bluebird bio
BLUE
| $53.4M | 0.07% |
60,841
-43,559
| -42% | -$31.6M |
|
|
B
302
Barrick Mining
B
$62.2B
| $53.1M | 0.07% |
2,996,358
-739,823
| -20% | -$14.8M |
|
303
Phillips 66
PSX
$82.9B
| $53M | 0.07% |
658,139
-304,440
| -32% | -$23.7M |
|
|
CLNY
304
DELISTED
Colony Capital, Inc.
CLNY
| $52.6M | 0.07% |
2,887,925
+233,240
| +9% | +$4.13M |
|
|
HES
305
DELISTED
Hess
HES
| $52.5M | 0.07% |
979,231
+711,733
| +266% | +$38.1M |
|
306
Cardinal Health
CAH
$53.4B
| $52.2M | 0.07% |
672,148
+128,431
| +24% | +$10.4M |
|
307
T-Mobile US
TMUS
$193B
| $52.1M | 0.07% |
1,115,942
-23,710
| -2% | -$1.09M |
|
308
Target
TGT
$62.1B
| $51.9M | 0.07% |
755,045
+102,508
| +16% | +$7.35M |
|
|
BERY
309
DELISTED
Berry Global Group, Inc.
BERY
| $51.8M | 0.07% |
1,287,042
+387,152
| +43% | +$15.2M |
|
310
Boeing
BA
$165B
| $51.7M | 0.06% |
392,480
+1,802
| +0.5% | +$237K |
|
311
Vail Resorts
MTN
$5.19B
| $51.7M | 0.06% |
329,293
+25,105
| +8% | +$3.83M |
|
|
SRC
312
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
| $51.3M | 0.06% |
+858,695
| New | +$51.1M |
|
|
SCHW
313
Charles Schwab
SCHW
$177B
| $51.3M | 0.06% |
1,624,577
+1,059,307
| +187% | +$31.1M |
|
314
Tesla
TSLA
$1.24T
| $51M | 0.06% |
3,750,000
| – | – |
|
315
American Electric Power
AEP
$73.7B
| $51M | 0.06% |
793,943
+27,362
| +4% | +$1.84M |
|
|
PE
316
DELISTED
PARSLEY ENERGY INC
PE
| $51M | 0.06% |
1,520,940
-271,160
| -15% | -$8.49M |
|
317
Neurocrine Biosciences
NBIX
$17.7B
| $50.8M | 0.06% |
1,002,548
+170,680
| +21% | +$8.5M |
|
318
Kinder Morgan
KMI
$73.1B
| $50.5M | 0.06% |
2,181,223
+474,609
| +28% | +$10.1M |
|
319
Digital Realty Trust
DLR
$73.7B
| $50.3M | 0.06% |
518,383
-271,419
| -34% | -$27.6M |
|
|
NFX
320
DELISTED
Newfield Exploration
NFX
| $50.1M | 0.06% |
1,152,344
+70,685
| +7% | +$3.11M |
|
321
Quest Diagnostics
DGX
$25.1B
| $50M | 0.06% |
591,045
+582,170
| +6,560% | +$48.9M |
|
322
Pentair
PNR
$10.2B
| $49.8M | 0.06% |
1,155,196
+1,076,574
| +1,369% | +$45.4M |
|
|
BDN
323
Brandywine Realty Trust
BDN
$551M
| $49.8M | 0.06% |
3,189,088
+1,506,191
| +89% | +$24.5M |
|
324
APA Corp
APA
$12.8B
| $49.8M | 0.06% |
779,685
+85,940
| +12% | +$4.7M |
|
|
SEP
325
DELISTED
Spectra Engy Parters Lp
SEP
| $49.8M | 0.06% |
1,139,837
-122,210
| -10% | -$5.64M |
|
Similar funds
TA
TCIM
HFS
SBAM
BB
SA
WF
BCPEM
OppenheimerFunds's Q3 2016 Portfolio in Review
As of Q3 2016, OppenheimerFunds held 1,817 positions worth $79.7B, up 4.5% from $76.2B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
OppenheimerFunds's Q3 2016 filing shows 122 new, 851 increased, 711 reduced and 96 closed positions. Its largest new stake was Fomento Económico Mexicano: 1,462,419 shares worth $135M. The largest sale was Bristol-Myers Squibb, an estimated $399M.
By sector, the portfolio is most concentrated in Energy at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.
- OppenheimerFunds's largest Q3 2016 buy was Fomento Económico Mexicano: 1,462,419 shares worth $135M.
- OppenheimerFunds added most to Johnson Controls International in Q3 2016, an estimated $281M increase.
- OppenheimerFunds's biggest Q3 2016 reduction was Bristol-Myers Squibb, cutting an estimated $399M.
- OppenheimerFunds fully exited UBS Group in Q3 2016, selling an estimated $393M.
- OppenheimerFunds's ten largest holdings make up 14% of its $79.7B portfolio in Q3 2016.
- OppenheimerFunds opened 122 new positions and closed 96 in Q3 2016.
- OppenheimerFunds's portfolio value rose 4.5% quarter-over-quarter to $79.7B.
Based on OppenheimerFunds's 13F filing for Q3 2016, filed 14 Nov 2016.